The costs of caring: Medical costs of Alzheimer's disease and the managed care environment

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in "managed" dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them.

Original languageEnglish (US)
Pages (from-to)168-178
Number of pages11
JournalJournal of Geriatric Psychiatry and Neurology
Volume14
Issue number4
DOIs
StatePublished - Jan 1 2001

Fingerprint

Cost of Illness
Managed Care Programs
Dementia
Alzheimer Disease
Costs and Cost Analysis
Quality of Health Care
Medicaid
Medicare
Disease Management
Health Expenditures
Organizations
Delivery of Health Care

ASJC Scopus subject areas

  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

The costs of caring : Medical costs of Alzheimer's disease and the managed care environment. / Murman, D. L.

In: Journal of Geriatric Psychiatry and Neurology, Vol. 14, No. 4, 01.01.2001, p. 168-178.

Research output: Contribution to journalReview article

@article{b7bde757408c46dbbd0858ef6f7ff2d6,
title = "The costs of caring: Medical costs of Alzheimer's disease and the managed care environment",
abstract = "This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in {"}managed{"} dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them.",
author = "Murman, {D. L.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1177/089198870101400402",
language = "English (US)",
volume = "14",
pages = "168--178",
journal = "Journal of Geriatric Psychiatry and Neurology",
issn = "0891-9887",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - The costs of caring

T2 - Medical costs of Alzheimer's disease and the managed care environment

AU - Murman, D. L.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in "managed" dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them.

AB - This review summarizes the medical costs associated with Alzheimer's disease (AD) and related dementias, as well as the payers responsible for these medical costs in the US health care system. It is clear from this review that AD and related dementias are associated with substantial medical costs. The payers responsible for a majority of these costs are families of patients with AD and the US government through the Medicare and Medicaid programs. In an attempt to control expenditures, Medicare and Medicaid have turned to managed care principles and managed care organizations. The increase in "managed" dementia care gives rise to several potential problems for patients with AD, along with many opportunities for systematic improvement in the quality of dementia care. Evidence-based disease management programs provide the greatest opportunities for improving managed dementia care but will require the development of dementia-specific quality of care measures to evaluate and continually improve them.

UR - http://www.scopus.com/inward/record.url?scp=0035185837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035185837&partnerID=8YFLogxK

U2 - 10.1177/089198870101400402

DO - 10.1177/089198870101400402

M3 - Review article

C2 - 11794445

AN - SCOPUS:0035185837

VL - 14

SP - 168

EP - 178

JO - Journal of Geriatric Psychiatry and Neurology

JF - Journal of Geriatric Psychiatry and Neurology

SN - 0891-9887

IS - 4

ER -